Adaptogens And Immune Function Research

Last updated: October 4, 2026 - Reviewed by Verdant Wellness Editorial Team

Estimated reading time: 14 minutes

Table of Contents

• What Are Adaptogens, Exactly?
• The Link Between Stress, Cortisol, and Immune Suppression
• Adaptogens and Immune Modulation: The Core Mechanisms
• Ashwagandha Immunity Research: Clinical Evidence Review
• Rhodiola Immune Function: From Lab to Marathon Runners
• Astragalus: The 1,000-Patient URI Study and Beyond
• Ginseng and Influenza Prevention in Elderly Populations
• Holy Basil Immunity: Adaptogen or Antioxidant?
• Adaptogen NK Cells: Natural Killer Cell Activation Research
• Adaptogens and Infection Resistance: Honest Assessment
• Long COVID Pilot Trial: What It Tells Us (And What It Doesn't)
• 2024 Research: Anti-Neuroinflammatory Effects and Signaling Pathways
• Are Adaptogens Safe Long Term? Drug Interactions and Contraindications
• Adaptogens vs. Vaccination: An Important Clarification
• Practical Guidance: Doses, Forms, and Realistic Expectations
• Frequently Asked Questions
• Conclusion

What Are Adaptogens, Exactly?

If you have spent any time browsing the wellness supplement aisle or scrolling through health-focused social media feeds, you have almost certainly encountered the word "adaptogen." It appears on protein powders, mushroom coffees, herbal tinctures, and stress-support capsules alike. But what does the term actually mean from a scientific and regulatory standpoint?

The concept of adaptogens originated in Soviet pharmacological research during the mid-twentieth century. Soviet scientist Nikolai Lazarev coined the term in 1947, and later his colleague Israel Brekhman helped formalize it with a definition that has largely persisted: an adaptogen is a natural substance that increases the nonspecific resistance of an organism to adverse influences, works through a broad and nonspecific mechanism, and normalizes physiological functions regardless of the direction of deviation from the norm.

In practical terms, this means adaptogens are theorized to help the body respond more effectively to stressors, whether those stressors are physical, chemical, biological, or psychological. Unlike a stimulant, which pushes a system in one direction, an adaptogen is classically described as a bidirectional normalizer. It is said to calm what is overactive and energize what is underactive.

The VA Whole Health Library, which is one of the top-ranking institutional resources currently covering this topic, defines adaptogens as "nontoxic plants that are marketed as helping the body resist the physical and mental effects of stress" and places them firmly in the category of herbal or botanical supplements used for stress resilience and related physiological support.

Commonly studied adaptogens include:

• Ashwagandha (Withania somnifera)
• Rhodiola rosea (golden root)
• Panax ginseng and Siberian ginseng (Eleutherococcus senticosus)
• Astragalus (Astragalus membranaceus)
• Holy basil / Tulsi (Ocimum tenuiflorum)
• Reishi mushroom (Ganoderma lucidum)
• Schisandra chinensis
• Eleuthero (E. senticosus)

Each of these plants carries its own chemical profile, traditional use history, and evolving clinical evidence base. When we discuss adaptogens immune system interactions, we are not talking about a single molecule or pathway. We are talking about a broad and pharmacologically diverse group of botanical compounds whose mechanisms overlap in some areas and diverge significantly in others.

With that foundational context established, let us move into the research that matters most to readers interested in immune function specifically.

The Link Between Stress, Cortisol, and Immune Suppression

To understand why adaptogens are studied in the context of immunity at all, you first need to understand the relationship between the stress hormone cortisol and immune function. This connection is one of the most thoroughly documented phenomena in psychoneuroimmunology, and it forms the biological rationale underlying nearly all research into herb immunity cortisol interactions.

When you experience a stressor, your hypothalamic-pituitary-adrenal (HPA) axis activates. The hypothalamus signals the pituitary gland, which in turn signals the adrenal glands to release cortisol. In short bursts, cortisol is anti-inflammatory and protective. It mobilizes energy, sharpens focus, and briefly suppresses immune responses to redirect resources toward immediate survival.

However, when cortisol remains chronically elevated, the immune consequences are significant and well-documented:

• Natural killer (NK) cell activity is suppressed, reducing the body's first line of defense against viral infections and nascent tumor cells
• Secretory immunoglobulin A (sIgA) levels decline, compromising mucosal immunity in the respiratory and gastrointestinal tracts
• T-lymphocyte proliferation is inhibited, slowing adaptive immune responses
• Pro-inflammatory cytokine dysregulation occurs, paradoxically increasing systemic low-grade inflammation even as targeted immune competence falls
• Neutrophil and macrophage function is impaired, reducing the speed and effectiveness of innate immune responses

This creates what researchers sometimes call the "immune paradox of chronic stress": the person under prolonged psychological or physiological stress is simultaneously more inflamed and less capable of fighting acute infections. They catch more colds. They experience longer recovery times. Their vaccine responses may be blunted.

It is precisely this pathway, the herb immunity cortisol axis, where adaptogens have generated the most mechanistically coherent evidence. If an herb demonstrably supports healthy cortisol output, buffers HPA axis reactivity, and supports normal glucocorticoid receptor sensitivity, then by extension it would be expected to partially restore immune competence. The question is whether the clinical evidence supports this theoretical chain of events.

The answer, as we will see throughout this article, is: sometimes, for some herbs, in some populations, with some caveats.

Adaptogens and Immune Modulation: The Core Mechanisms

Before diving into individual herbs, it is worth establishing what "adaptogens immune modulation" actually means mechanistically, because the term is used somewhat loosely in both research and marketing contexts.

Immune modulation is not the same as immune stimulation. Immune stimulation suggests a simple upward push on immune activity across the board. Immune modulation suggests a more nuanced recalibration of immune activity in context, sometimes upregulating deficient responses and sometimes dampening excessive inflammatory activity. This distinction matters enormously for clinical applications.

The primary mechanisms through which adaptogens are theorized to modulate immune function include:

1. HPA Axis Regulation and Cortisol Buffering As described above, reducing chronic cortisol elevation can restore suppressed immune activity. Several adaptogens, most notably ashwagandha and rhodiola, have demonstrated HPA axis modulating activity in human clinical trials.

2. Direct NK Cell Activation Some adaptogenic compounds appear to directly upregulate NK cell cytotoxicity independent of cortisol pathways. This has been shown for certain ginsenosides from Panax ginseng and for beta-glucans from reishi and other medicinal mushrooms.

3. Cytokine Regulation Several adaptogens influence the production and signaling of key immune cytokines. Relevant cytokines studied include interferon-gamma (IFN-γ), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and tumor necrosis factor alpha (TNF-α). The 2024 mini-review published in PMC specifically documents how compounds from E. senticosus, W. somnifera, and R. rosea inhibited genes involved in leukotriene synthesis in vitro, while gomisin A from schisandra reduced TNF-α, IL-1β, and IL-6 in microglial cells.

4. NF-κB and MAPK Signaling Pathways These two intracellular signaling pathways are central regulators of inflammatory and immune gene expression. Inhibiting NF-κB typically has anti-inflammatory effects, while MAPK pathway modulation can influence both pro- and anti-inflammatory gene expression depending on context. Multiple adaptogenic compounds have demonstrated activity at these pathways.

5. Toll-Like Receptor (TLR) Agonism Some polysaccharides from adaptogenic herbs, particularly astragalus polysaccharides, appear to activate toll-like receptors, which are pattern recognition receptors that initiate innate immune responses.

6. Antibody Production Enhancement Particularly with astragalus, studies have noted effects on immunoglobulin levels, which would reflect enhanced adaptive immune memory.

7. Interferon Induction Astragalus has been associated with higher interferon levels in prior studies, which would support antiviral resistance.

Understanding these mechanisms helps separate genuine adaptogen immune enhancement from marketing language. The best-supported claims are not "this herb will make your immune system stronger." They are more precisely: "this herb may partially restore immune competence that was suppressed by chronic stress, may activate specific immune cell populations, and may modulate cytokine production in particular directions."

★★★★★ 4.8 · 1,247 reviews

Feel Calm By Bedtime. Focused By Morning.

Adaptogen-based formula. Third-party tested. Made in an FDA-registered facility. Backed by a 60-day money-back guarantee.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Ashwagandha Immunity Research: Clinical Evidence Review

Ashwagandha (Withania somnifera) is arguably the most widely studied adaptogen in contemporary Western research, and the ashwagandha immunity research base has grown substantially over the past decade. It is also one of the most commercially successful adaptogenic supplements in the North American and European markets.

Active Compounds The primary bioactive compounds in ashwagandha are a class of steroidal lactones called withanolides, particularly withaferin A. Withanolides have demonstrated immunomodulatory, anti-inflammatory, and antioxidant activity across multiple in vitro and animal model studies.

Ashwagandha and Cortisol: The Human Clinical Data The most consistently replicated finding in ashwagandha clinical research is a measurable reduction in serum cortisol. A frequently cited 2012 randomized controlled trial by Chandrasekhar et al., published in the Indian Journal of Psychological Medicine, found that 300 mg of high-concentration ashwagandha root extract taken twice daily for 60 days produced a statistically significant 27.9% reduction in serum cortisol compared to placebo. Given the cortisol-immune suppression relationship outlined earlier, this finding has direct relevance to immune health, even when the studies do not measure immune endpoints directly.

Ashwagandha Immune Clinical Evidence: Direct Immune Endpoints Moving specifically to ashwagandha immune clinical studies with direct immune outcome measures, the data are promising but limited in scope and size.

A 2021 pilot study published in the Journal of Clinical Medicine examined the effects of ashwagandha supplementation on immune parameters in healthy adults. Findings included:

• Increased immunoglobulin M (IgM) levels
• Increased immunoglobulin G (IgG) levels
• Increased immunoglobulin A (IgA) levels
• Modest enhancement in NK cell activity

These are meaningful immune endpoints, but the study was small and short in duration. The signal is interesting; the evidence does not yet warrant strong clinical claims.

Ashwagandha and NK Cells Within the adaptogen NK cells research category, ashwagandha shows one of the more consistent signals. NK cells are innate immune lymphocytes that circulate continuously surveilling for virally infected cells and malignant cells. Because chronic stress is one of the primary suppressors of NK cell activity, and because ashwagandha demonstrably supports healthy cortisol, a restored NK cell population would be mechanistically expected.

Some studies have specifically measured NK cell cytotoxicity, finding increases after ashwagandha supplementation. However, the clinical significance of these increases, meaning whether they translate to fewer infections or faster recovery, remains under-studied in well-designed trials.

What Doses Are Used in Research? The majority of ashwagandha clinical trials use doses ranging from 300 mg to 600 mg of standardized root extract daily, typically standardized to 5% withanolides. Some research uses higher doses. Duration in most trials ranges from 8 to 12 weeks.

Honest Assessment Ashwagandha shows a coherent biological story: it supports healthy cortisol, and cortisol reduction is associated with improved immune parameters. Some studies have measured those immune parameters directly and found positive changes. However, the leap from "improved immune parameters in a clinical trial" to "will prevent you from getting sick" is not yet supported by robust outcome data. Long-term randomized controlled trials measuring actual infection incidence, severity, and duration are still largely absent from the literature.

Rhodiola Immune Function: From Lab to Marathon Runners

Rhodiola rosea, commonly known as golden root or Arctic root, has a long history of use in Russian and Scandinavian traditional medicine, and it occupies a somewhat unique position in adaptogen research. The rhodiola immune function literature spans basic science studies, athlete-focused trials, and emerging anti-inflammatory pathway work.

Rhodiola's Adaptogenic Credentials SupplySide Supplement Journal reports that multiple clinical trials have confirmed Rhodiola rosea's adaptogenic effects, including improved physical performance and stress-related fatigue reduction. These trials have established rhodiola's adaptogenic credibility more firmly than many other herbs in the category, making it one of the most credible candidates when evaluating adaptogens immune system interactions.

The Marathon Runner Antiviral Study One of the most intriguing findings in rhodiola immune function research is a study noting increased antiviral activity in marathon runners who used rhodiola supplementation. This is particularly noteworthy for several reasons.

Marathon running is a canonical model for studying exercise-induced immune suppression. Endurance athletes experience a well-documented post-race "open window" of immune vulnerability, during which upper respiratory infection rates rise sharply. This is not simply due to fatigue. It involves measurable suppression of salivary IgA, NK cell activity, and mucosal immune defenses, partially driven by acute cortisol and adrenaline spikes.

Finding that rhodiola supplementation increased antiviral activity in this population is mechanistically coherent. If rhodiola buffers stress hormone release and attenuates HPA axis overactivation during extreme physical stress, the downstream immune restoration would be expected. The study cited by SupplySide represents an applied real-world stress mode l that is arguably more relevant to everyday immune health than many controlled laboratory studies.

Rosavin and Salidroside: The Active Compounds Rhodiola's primary active compounds are rosavins and salidroside. Salidroside in particular has shown interesting anti-inflammatory activity in precellular and animal studies, including inhibition of pro-inflammatory cytokine expression.

The 2024 PMC mini-review specifically includes R. rosea extracts among compounds that inhibited genes involved in leukotriene synthesis in vitro. Leukotrienes are lipid inflammatory mediators involved in allergic and asthmatic responses, and their inhibition represents a genuinely anti-inflammatory mechanism.

Rhodiola and Exercise Immune Modulation Beyond the marathon study, rhodiola has been examined in other exercise contexts for immune endpoints. The general pattern of findings suggests:

• Reduced exercise-induced inflammatory cytokine release
• Attenuated post-exercise cortisol spikes
• Possible preservation of immune cell function during recovery windows

Limitations Most rhodiola immune studies are small. Some are conducted in highly specific populations (elite athletes, institutionalized elderly) that may not generalize broadly. Direct comparisons between rhodiola and other adaptogens for immune endpoints are rare. The overall signal is promising but not yet definitive.

Astragalus: The 1,000-Patient URI Study and Beyond

Of all the adaptogens with immune-focused clinical evidence, astragalus (Astragalus membranaceus) arguably has the most directly relevant traditional use history and some of the most striking large-scale clinical data.

The 1,000-Patient Study The VA Whole Health Library cites a 1,000-patient Chinese study as supporting astragalus for upper respiratory infection (URI) prevention. A study of this size would represent substantial evidence in the adaptogen research landscape, where most trials involve dozens rather than hundreds of participants. Upper respiratory infections (the common cold and related illnesses) are precisely the category of outcomes most relevant to everyday immune resilience, making this finding particularly noteworthy for readers asking whether adaptogens and infection resistance is a real phenomenon.

It is worth noting that the study originates from Chinese clinical research, which has received methodological scrutiny in some systematic reviews. However, the VA Whole Health Library's inclusion of this evidence reflects institutional recognition of its relevance, and it aligns with a broader pattern of astragalus findings.

White Blood Cell Function, Antibody Levels, and Interferon The VA reports that regular astragalus use has been associated with improved white blood cell function, higher antibody levels, and higher interferon levels in prior studies. These three markers collectively represent a meaningful snapshot of immune competence:

• White blood cell function: Reflects both innate (neutrophils, macrophages) and adaptive (lymphocyte) immune readiness
• Higher antibody levels: Suggests enhanced humoral immune memory and response capacity
• Higher interferon levels: Interferons are signaling proteins that play a central role in antiviral defense, essentially warning neighboring cells that a viral infection is present and triggering antiviral programs

This combination of endpoints is more comprehensive than most adaptogen studies report, and it makes astragalus one of the most credible herbs in the category when discussing adaptogen immune enhancement specifically.

Astragalus Polysaccharides The primary immunologically active compounds in astragalus are polysaccharides (APS), particularly astragalan. These polysaccharides appear to function as toll-like receptor agonists and have been studied for their ability to activate macrophages, stimulate T-cell proliferation, and enhance NK cell activity. Beta-glucan-like polysaccharide activity is also found in medicinal mushrooms (reishi, shiitake, maitake), creating some mechanistic overlap between astragalus and functional fungi.

Astragalus in Combination with Standard Treatments Chinese traditional medicine frequently uses astragalus in combination with other herbs rather than as a standalone compound. Many of the positive clinical studies reflect combination formulas rather than isolated astragalus. This complicates attribution of effects to astragalus specifically.

Astragalus and Autoimmune Considerations Because astragalus appears to stimulate or enhance certain immune activities, there is theoretical concern about its use in people with autoimmune conditions where immune upregulation could be harmful. This is an area requiring clinical caution and physician consultation.

★★★★★ 4.8 · 1,247 reviews

The Adaptogens Your Nervous System Has Been Missing.

Ashwagandha, rhodiola, and phosphatidylserine — clinically-studied ingredients that support healthy cortisol rhythms.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Ginseng and Influenza Prevention in Elderly Populations

Panax ginseng occupies a central position in the adaptogens immune system research literature, and it carries the distinction of being studied alongside one of the most clinically meaningful immune endpoints available: influenza infection rates in vaccine-receiving populations.

The VA Evidence: Institutionalized Elderly and Flu Risk The VA Whole Health Library notes that ginseng has been shown to decrease the risk of influenza in institutionalized elderly individuals, often studied alongside influenza vaccination. This finding deserves careful unpacking.

Institutionalized elderly populations (nursing home residents, long-term care patients) are among the most vulnerable to influenza morbidity and mortality. They also tend to mount weaker antibody responses to influenza vaccination due to immunosenescence, the gradual decline in immune function that accompanies aging. If ginseng supplementation can either reduce infection rates or enhance vaccine response in this population, it represents a clinically meaningful application of adaptogen immune modulation.

Studies examining ginseng in this context have typically used standardized Panax ginseng extract at doses of 100 mg to 400 mg daily for periods ranging from 8 weeks to 6 months. Some have found:

• Reduced incidence of acute respiratory illness
• Reduced severity and duration of cold and influenza symptoms
• Enhanced antibody titers following influenza vaccination

Ginsenosides and Their Immune Mechanisms The primary active compounds in Panax ginseng are ginsenosides, a family of steroidal saponins. Different ginsenosides have different and sometimes opposing physiological effects, which partly explains why the research on ginseng can appear inconsistent. Ginsenoside Rg1 has demonstrated immunostimulatory activity, while Rb1 is more associated with neuroprotective and anti-inflammatory effects.

From an immune perspective, ginsenosides have been shown to:

• Enhance NK cell cytotoxicity (relevant to the adaptogen NK cells category)
• Increase T-cell and B-cell proliferative responses
• Stimulate macrophage phagocytic activity
• Modulate interferon production

Siberian Ginseng vs. Panax Ginseng It is important to distinguish between Panax ginseng (true ginseng) and Siberian ginseng (Eleutherococcus senticosus), which are botanically unrelated despite sharing the common name. The 2024 PMC mini-review specifically includes E. senticosus among adaptogens demonstrating anti-neuroinflammatory effects, with extracts inhibiting genes involved in leukotriene synthesis. While both are used as adaptogens, their chemical profiles and evidence bases differ substantially.

Realistic Assessment Ginseng's immune evidence is arguably more clinically grounded than most adaptogens because it has been studied in high-risk populations against meaningful infection endpoints rather than just biomarker changes. However, the studies are not without limitations: many are industry-funded, populations vary, and ginseng preparations are notoriously inconsistent in standardization.

Holy Basil Immunity: Adaptogen or Antioxidant?

Holy basil, known in Ayurvedic medicine as Tulsi (Ocimum tenuiflorum), holds deep cultural and medicinal significance in South Asian traditions and is gaining increasing attention in Western integrative medicine contexts. Its classification specifically as an adaptogen is debated, but its relevance to discussions of holy basil immunity is well-established.

Active Compounds in Holy Basil Tulsi contains a diverse array of bioactive compounds, including:

• Eugenol: A phenylpropanoid with anti-inflammatory and antimicrobial properties
• Ursolic acid: A pentacyclic triterpenoid with anti-inflammatory, antiviral, and immunomodulatory effects
• Rosmarinic acid: A polyphenol with antioxidant and anti-inflammatory activity
• Ocimumosides A and B: Compounds proposed to have adaptogenic activity through HPA axis modulation

Holy Basil and Immune Function Research In vitro and animal studies have suggested that tulsi extracts can:

• Enhance NK cell activity
• Increase T-helper cell (CD4+) populations
• Reduce expression of pro-inflammatory cytokines
• Demonstrate direct antimicrobial activity against certain pathogens

Human clinical evidence for holy basil immunity specifically remains less developed than for ashwagandha or ginseng. Some small randomized trials have examined tulsi's effects on general wellness markers, cognitive function, and stress, finding modest positive effects. Direct immune endpoint data from large human trials is limited.

The Adaptogen vs. Antioxidant Debate Some researchers classify tulsi's primary mechanism as antioxidant rather than classically adaptogenic. Its demonstrated capacity to reduce oxidative stress markers and support mitochondrial health may underpin its stress-protective effects indirectly rather than through direct HPA axis modulation. This distinction matters for how we categorize its immune effects: antioxidant-mediated immune support is a real phenomenon, but it operates through different pathways than cortisol buffering or direct cytokine modulation.

Herb Immunity Cortisol: Tulsi's HPA Axis Evidence Some animal studies and preliminary human data suggest that tulsi does modulate cortisol output, supporting its classification as an adaptogen within the herb immunity cortisol framework. However, the human trials are small and the cortisol effects appear to be more modest than those documented for ashwagandha.

Practical Role Holy basil is often consumed as a tea (tisane) rather than as a standardized extract supplement. Bioavailability and dosing consistency differ between these forms. As an immune support tool, it is likely best positioned as a complementary addition to other better-evidenced herbs rather than as a primary immune intervention.

Adaptogen NK Cells: Natural Killer Cell Activation Research

Natural killer cells deserve a focused section because they are among the most immunologically relevant endpoints in adaptogen research, and because the adaptogen NK cells literature is more developed than many readers realize.

What Are NK Cells and Why Do They Matter? Natural killer cells are innate lymphocytes that patrol the body searching for cells that display signs of viral infection or malignant transformation. Unlike T-cells, which require previous antigen exposure (the adaptive immune learning process), NK cells respond to stressed, infected, or cancerous cells without prior sensitization. This makes them a critical first-line defense, particularly against viral respiratory infections.

NK cell activity is measured in research as cytotoxicity, meaning the percentage of target cells killed per NK cell in a controlled assay. Chronic psychological stress, sleep deprivation, extreme exercise, and aging all reduce NK cell cytotoxicity in measurable and clinically relevant ways.

Adaptogens With NK Cell Data The following adaptogens have some level of published evidence for NK cell modulation:

Ashwagandha: Multiple studies, including the 2021 pilot study mentioned earlier, have found increased NK cell activity following ashwagandha supplementation. The mechanism is likely multifactorial, involving both cortisol reduction and possible direct immunostimulatory effects of withanolides.

Panax Ginseng: Ginsenosides, particularly Rg1, have been shown to enhance NK cell cytotoxicity in both in vitro and human studies. The enhancement is generally modest in magnitude but statistically reliable across studies.

Reishi Mushroom: Beta-glucans from Ganoderma lucidum are among the best-characterized natural NK cell activators. Beta-glucans bind to dectin-1 receptors on immune cells, triggering downstream activation. Reishi is sometimes grouped with adaptogens in functional medicine contexts despite not meeting all classical adaptogen criteria.

Astragalus: Astragalus polysaccharides have demonstrated NK cell-activating effects in multiple studies, consistent with their broader immunostimulatory profile.

Eleuthero (Siberian Ginseng): Some human studies in athletes and elderly populations have noted preserved or enhanced NK cell numbers during periods of physical or age-related immune stress.

Clinical Significance An important and often-overlooked question is whether statistically significant increases in NK cell cytotoxicity measured in a blood sample translate to clinical benefits like fewer viral infections or faster cancer surveillance. The answer is likely yes in cases where baseline NK activity is suppressed (stress, aging, post-exercise), but less clear when baseline activity is already normal. This nuance is rarely captured in marketing claims but is essential for informed consumer decision-making.

Adaptogens and Infection Resistance: Honest Assessment

This is the question most readers come here with: do adaptogens actually help you get sick less often? Can adaptogens and infection resistance be meaningfully linked in clinical terms?

What the Evidence Actually Shows Let us separate the evidence into tiers based on quality and specificity:

Strong Signal (Multiple Studies, Direct Infection Endpoints)

• Astragalus for upper respiratory infection prevention (the 1,000-patient study and supporting smaller trials)
• Panax ginseng for reduced influenza risk in elderly populations alongside vaccination

Moderate Signal (Plausible Mechanism, Limited Direct Evidence)

• Ashwagandha: consistent cortisol reduction and NK cell enhancement, limited trials measuring actual infection incidence
• Rhodiola: antiviral activity in marathon runners, plausible mechanism, limited replication
• Eleuthero: some URI endpoint data in older Eastern European literature, methodological concerns

Weak Signal (Primarily In Vitro or Animal Data)

• Holy basil: compelling basic science, limited human infection endpoint data
• Schisandra: interesting cytokine data, limited clinical infection research

The Specificity Problem Even in the strongest categories, we face a specificity problem. "Upper respiratory infection prevention" is the outcome endpoint in the astragalus URI studies. Does that mean astragalus will prevent your specific cold? Reduce its severity if you do get it? Shorten its duration? Different studies measure different endpoints, and the answer to "do adaptogens prevent infections" depends heavily on which herb, which pathogen, which population, and which outcome measure.

Infection Incidence vs. Immune Biomarkers The majority of adaptogen studies measure immune biomarkers (NK cell activity, cytokine levels, antibody titers) rather than direct infection outcomes. Improved biomarkers are promising proxies but not the same as confirmed clinical benefit. Higher NK cell activity in a blood sample does not automatically equal fewer days with the flu.

Population Context Matters Enormously The strongest evidence for adaptogens and infection resistance comes from populations under defined immune pressure: elderly individuals (immunosenescence), elite athletes (exercise-induced immune suppression), chronically stressed adults (cortisol-mediated immunosuppression), and institutionalized populations with high infectious disease exposure. Evidence may not generalize to healthy young adults with normal immune function and low stress levels.

Long COVID Pilot Trial: What It Tells Us (And What It Doesn't)

The COVID-19 pandemic generated significant interest in botanical immunology, including whether adaptogenic herbs could support recovery from Long COVID, the constellation of persistent symptoms affecting a substantial proportion of people following acute SARS-CoV-2 infection.

The Pilot Trial McGill University's reporting references a contemporary pilot trial of an adaptogen blend in Long COVID patients. The trial findings are worth examining carefully because they illustrate both the promise and the methodological challenges of adaptogen immune research.

What the Study Found McGill reports that symptom scores improved in both the placebo and adaptogen groups over 3 weeks. The placebo-controlled between-group effects were described as limited and inconsistent. The adaptogen blend did show some differences versus placebo for coughing, daily walk time, creatinine, and interleukin-6, but the overall evidence was characterized as weak.

What This Actually Means Several observations are worth making:

First, improvement in both groups over 3 weeks is not surprising in Long COVID research. Natural symptom improvement trajectories over time create significant placebo response challenges in this population, and 3 weeks is a short observation window for a complex post-viral syndrome.

Second, the finding of some between-group differences for specific endpoints (coughing, daily walk time, interleukin-6) is actually scientifically interesting even if not statistically robust. Interleukin-6 is a pro-inflammatory cytokine centrally implicated in Long COVID pathophysiology, and a reduction in IL-6 in the adaptogen group would be mechanistically coherent with the anti-inflammatory profiles discussed throughout this article.

Third, the McGill characterization of the evidence as "weak" and "highly sensitive to subgroup slicing" is a fair representation of the trial's limitations. Pilot trials are not designed to provide definitive answers. They are designed to establish safety, estimate effect sizes, and inform the design of adequately powered trials. A pilot trial showing any signal in a difficult-to-treat condition with complex immunopathology is not a failure; it is a hypothesis generator.

The Critical Takeaway Long COVID research is still young, the mechanisms driving persistent symptoms are incompletely understood, and adaptogens have not been established as treatments for Long COVID. The pilot data is hypothesis-generating at best. Patients with Long COVID should not substitute adaptogen supplements for evidence-based medical care.

2024 Research: Anti-Neuroinflammatory Effects and Signaling Pathways

The most recent research to add meaningful data to the adaptogens and immune function research landscape comes from a 2024 mini-review published in PMC examining the anti-neuroinflammatory effects of adaptogenic herbs.

Why Neuroinflammation Matters for Immunity Neuroinflammation, inflammation within the central nervous system, is mediated by microglia, the brain's resident immune cells. While neuroinflammation is not the same as systemic immune function, it is increasingly recognized as relevant to post-viral syndromes, autoimmune conditions, and the chronic inflammation associated with prolonged stress. Understanding how adaptogens modulate microglial activity extends our understanding of their broader immunomodulatory capacities.

Key 2024 Findings

Leukotriene Synthesis Inhibition The 2024 mini-review reports that extracts of E. senticosus (Siberian ginseng), W. somnifera (ashwagandha), and R. rosea (rhodiola) inhibited genes involved in leukotriene synthesis in vitro. Leukotrienes are lipid mediators derived from arachidonic acid that drive allergic inflammation, airway constriction, and immune cell recruitment. Inhibiting leukotriene synthesis would theoretically reduce certain types of inflammatory immune responses, suggesting potential applications in allergy-related immune modulation.

Gomisin A and Microglial Cytokine Suppression Gomisin A, a lignan from Schisandra chinensis (a less commonly discussed adaptogen), was found to reduce TNF-α, IL-1β, and IL-6 in microglial cells. Critically, the mechanism involved inhibition of NF-κB and MAPK-related inflammatory signaling pathways.

This finding is significant for several reasons:

• TNF-α, IL-1β, and IL-6 are three of the most important pro-inflammatory cytokines in the human immune system, involved in fever, acute phase responses, and inflammatory cascades
• NF-κB is sometimes called the "master regulator of inflammation," and its inhibition is the mechanism of action of many established anti-inflammatory drugs
• MAPK pathway inhibition has implications for both inflammatory and immune cell survival signaling

Finding that a naturally occurring schisandra compound modulates these pathways at the cellular level provides compelling mechanistic support for investigating schisandra as a genuine immune modulator.

Implications for Adaptogen Immune Enhancement The 2024 research supports the view that adaptogen immune enhancement, at least for some herbs and compounds, operates through real and identifiable biochemical pathways rather than simply through vague "immune boosting" effects. The transition from in vitro findings to human clinical significance requires further research, but the mechanistic scaffolding is becoming increasingly detailed and credible.

★★★★★ 4.8 · 1,247 reviews

See Why Athletes And Executives Take It Daily.

Adaptogen-based formula, third-party tested, made in the USA. Cancel subscription anytime.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Are Adaptogens Safe Long Term? Drug Interactions and Contraindications

No evidence-based guide to adaptogens and immune function research would be complete without an honest discussion of safety, drug interactions, and the populations for whom caution is warranted.

General Safety Profile Most commonly studied adaptogens have relatively favorable safety profiles in healthy adults when used at clinically studied doses for defined periods. The classical definition of an adaptogen includes nontoxicity as a core criterion, and this is generally supported by available human safety data for ashwagandha, rhodiola, holy basil, eleuthero, and astragalus.

However, "generally favorable safety profile" is not the same as "safe for everyone in any dose for any duration." Nuance matters here.

Ashwagandha: Liver Safety Signals Ashwagandha has accumulated case reports of hepatotoxicity (liver injury). While these cases are rare relative to the number of people using the herb, they are serious. The FDA and some regulatory agencies have noted these signals. Individuals with pre-existing liver conditions, those taking hepatotoxic medications, or those consuming high doses should exercise caution and monitor liver function with medical supervision.

Ginseng: Stimulant-Like Effects and Interactions Panax ginseng can produce stimulant-like side effects at higher doses or in sensitive individuals, including insomnia, irritability, hypertension, and palpitations. It has documented interactions with:

• Warfarin and anticoagulants: May reduce anticoagulant effects
• Stimulant medications: Additive effects
• Diabetic medications: May have additive blood glucose-lowering effects
• MAOIs: Potential for adverse interactions

Rhodiola: Generally Well-Tolerated Rhodiola is considered one of the better-tolerated adaptogens. Side effects are typically mild (dizziness, dry mouth, insomnia at high doses). Interactions are less documented than for ginseng, but caution with serotonergic medications is sometimes noted.

Astragalus: Autoimmune and Immunosuppressant Concerns Because astragalus appears to enhance certain immune functions, it may theoretically worsen autoimmune conditions or interfere with immunosuppressant medications (such as those used after organ transplantation or for autoimmune diseases). People on immunosuppressive therapy should not take astragalus without explicit medical guidance.

Pregnancy and Breastfeeding Most adaptogens lack adequate safety data for pregnancy and breastfeeding. The general recommendation is to avoid use during these periods unless under direct medical supervision.

Drug Interactions: A Framework Adaptogens that modulate cytochrome P450 enzymes (the liver's drug-metabolizing enzyme system) can theoretically alter blood levels of many medications. Ginseng and ashwagandha have both shown some CYP enzyme modulating activity. Anyone taking prescription medications should consult a healthcare provider before starting adaptogen supplementation.

Long-Term Use Clinical trials generally study adaptogens for 8 to 12 weeks, occasionally up to 6 months. Long-term safety data beyond 12 months is limited for most adaptogens. Traditional use for longer periods exists, but this does not establish safety in contemporary medical terms, particularly with standardized extracts at higher-than-traditional doses.

The Practical Guidance For most healthy adults without autoimmune conditions, chronic inflammatory diseases, or polypharmacy concerns, short-to-medium-term use of well-sourced, standardized adaptogen extracts at clinically studied doses carries modest risk. But individual circumstances vary, and consultation with a physician or qualified herbalist is valuable, particularly for people with health conditions or on medications.

Adaptogens vs. Vaccination: An Important Clarification

This question deserves direct and unambiguous treatment: adaptogens are not a substitute for vaccination or evidence-based medical treatment for infectious disease.

The evidence most supportive of adaptogens in immune contexts specifically positions them as adjunctive tools, meaning alongside vaccination and standard care, not instead of it. The VA's ginseng data, for instance, is specifically described in the context of studies conducted alongside influenza vaccination, not as a replacement for it.

Vaccines work through a completely different mechanism than adaptogens. They train the adaptive immune system to recognize specific pathogen antigens, creating immunological memory that enables rapid and targeted responses upon real exposure. No adaptogen replicates this mechanism or provides pathogen-specific immunity.

Where adaptogens may plausibly add value in infectious disease contexts:

• Supporting vaccine response: If an adaptogen supports healthy cortisol and HPA axis overactivation, it may partially restore blunted vaccine antibody responses in chronically stressed or elderly individuals (this is the most plausible vaccine-adjacent application)
• Reducing non-specific infection risk: Through the URI prevention and general immune enhancement mechanisms discussed throughout this article
• Supporting recovery: By modulating inflammatory responses and reducing immune suppression during recovery periods

What adaptogens cannot do:

• Provide pathogen-specific protection the way vaccines do
• Treat active serious infections
• Replace antibiotic therapy for bacterial infections
• Substitute for antiviral medications in high-risk viral infections

This is not a diminishment of adaptogens. It is a proper positioning of them within a broader immune health toolkit.

Practical Guidance: Doses, Forms, and Realistic Expectations

For readers who have reached this point and are considering incorporating adaptogens into their immune health routine, here is pragmatic guidance drawn from the clinical evidence reviewed above.

Evidence-Based Dosing Summary

| Herb | Typical Research Dose | Duration in Studies | Standardization | |------|----------------------|---------------------|-----------------| | Ashwagandha | 300–600 mg/day | 8–12 weeks | 5% withanolides | | Rhodiola | 200–600 mg/day | 4–12 weeks | 3% rosavins, 1% salidroside | | Panax Ginseng | 100–400 mg/day | 8–24 weeks | 4–7% ginsenosides | | Astragalus | 500–1,000 mg/day | 6–12 weeks | Astragalus polysaccharides | | Holy Basil | 300–600 mg/day | 4–8 weeks | Variable |

Forms: Extract vs. Whole Herb Most clinical studies use standardized extracts rather than crude whole-herb preparations. Standardized extracts specify a minimum percentage of key active compounds, which provides dosing consistency that whole-herb preparations cannot guarantee. For immune purposes, standardized extracts offer better alignment with research findings.

Timing and Cycling Some practitioners recommend cycling adaptogens (e.g., 6 weeks on, 2 weeks off) to prevent physiological accommodation, though this practice is not strongly supported by clinical evidence. There is theoretical rationale but limited research.

Quality and Sourcing Supplement quality varies enormously. Key markers of quality:

• Third-party testing certification (NSF, USP, Informed Sport)
• Standardization to active compounds documented in research
• Clear statement of extract ratio (e.g., 5:1) or active compound percentage
• Transparent manufacturing standards (GMP-certified facilities)

Realistic Expectations The most honest summary of what adaptogen supplementation might do for immune function in a generally healthy adult:

• Partially buffer cortisol-mediated immune suppression if you are chronically stressed
• Modestly enhance NK cell activity and certain antibody responses
• Potentially reduce upper respiratory infection frequency over a supplementation period
• Support recovery after extreme physical exertion by reducing post-exercise immune window

What it will not do with high confidence:

• Prevent all infections
• Treat active illnesses
• Substitute for sleep, nutrition, and stress management as immune foundations
• Produce dramatic, rapid immune transformations

Frequently Asked Questions

What are adaptogens, exactly? Adaptogens are a class of herbal substances that theoretically increase non-specific resistance to stress (physical, chemical, biological, or psychological) while normalizing physiological functions without major toxicity. Examples include ashwagandha, rhodiola, ginseng, astragalus, and holy basil. The term was coined in Soviet pharmacological research in the 1940s.

Do adaptogens really support immune function? The honest answer is: some adaptogens appear to modulate specific aspects of immune function in specific contexts, but the evidence quality varies by herb and population. Astragalus and ginseng have the most direct clinical evidence for infection-relevant immune endpoints. Ashwagandha has strong cortisol-reduction data with associated immune restoration logic. Rhodiola has interesting data in athletes. Calling all adaptogens "immune boosters" overstates the evidence.

Which adaptogens are best for immunity? Based on available clinical evidence: astragalus (strongest direct URI prevention data), Panax ginseng (strongest data in elderly for influenza prevention), ashwagandha (strongest cortisol/NK cell data), and rhodiola (antiviral activity in athletes). Holy basil and schisandra have interesting mechanistic data but less robust human clinical evidence.

Is there clinical evidence for ginseng, astragalus, reishi, or rhodiola? Yes, to varying degrees. Ginseng and astragalus have the strongest large-population clinical evidence. Rhodiola has multiple well-designed trials for stress and fatigue with some immune-adjacent data. Reishi's beta-glucan content has good immunostimulatory evidence, though reishi specifically as an adaptogen is debated.

Can adaptogens help prevent colds, flu, or respiratory infections? The evidence is most supportive for astragalus (URI prevention in a 1,000-patient study) and ginseng (reduced influenza risk in elderly). For other adaptogens, the evidence is more mechanistic and indirect. These are not zero-evidence claims, but they are not as strong as, for example, vaccine evidence for influenza prevention.

Are adaptogens safe to take long term? Most have reasonable safety profiles for medium-term use (up to 12 months). Ashwagandha has rare but serious hepatotoxicity case reports. People with autoimmune conditions should be cautious with astragalus. Long-term data beyond 12 months is limited. Physician consultation is appropriate for prolonged use, especially in those with health conditions or on medications.

Do adaptogens interact with medications or chronic conditions? Yes, potentially. Ginseng interacts with anticoagulants, diabetic medications, and MAOIs. Ashwagandha may interact with thyroid medications and has liver concerns. Astragalus may interfere with immunosuppressants. Anyone on regular prescription medications should consult a healthcare provider before starting adaptogens.

Are adaptogens a substitute for vaccination or standard treatment? No. Adaptogens are adjunctive at best. They do not provide pathogen-specific immunity, cannot treat active serious infections, and should not replace evidence-based medical interventions including vaccination.

What dose is used in studies? Doses vary by herb. Ashwagandha typically uses 300–600 mg of standardized extract. Rhodiola studies use 200–600 mg. Panax ginseng studies typically use 100–400 mg of standardized extract. Astragalus studies have used 500–1,000 mg. Standardized extracts (not crude powders) are typically used in quality research.

What is the difference between stress support and immune modulation? Stress support refers primarily to reducing HPA axis overactivation, lowering cortisol, and improving psychological resilience to stressors. Immune modulation refers to direct or indirect effects on immune cell populations, cytokine production, or antibody responses. These overlap significantly because chronic cortisol elevation suppresses immune function, meaning stress support indirectly provides immune modulation. But some adaptogens appear to have direct immune effects (NK cell activation, polysaccharide TLR agonism) that go beyond stress hormone management.

★★★★★ 4.8 · 1,247 reviews

Ready To Try Adaptogen-Based Cortisol Support?

Third-party tested. 60-day guarantee. Free shipping over $40. Ships in 24 hours.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Conclusion

The research on adaptogens and immune function has matured considerably from its origins in Soviet pharmacology into an active and genuinely interesting area of evidence-based botanical medicine. The picture that emerges from the full literature review is neither the wildly optimistic one presented in supplement marketing nor the dismissive one sometimes encountered in mainstream skeptic commentary.

Several important conclusions stand up to scrutiny:

The HPA axis-immune connection is real and significant. Chronic cortisol elevation demonstrably suppresses immune function across multiple parameters. Adaptogens that reliably support healthy cortisol output, most convincingly ashwagandha at studied doses, therefore have a mechanistically sound pathway to immune support, even when studies do not measure immune endpoints directly.

Astragalus and ginseng have the most direct clinical evidence for infection-relevant outcomes. A 1,000-patient URI prevention study for astragalus and ginseng data in elderly influenza populations represent meaningful clinical signals that go beyond biomarker changes. These findings support positioning these herbs as having genuine, if modest, roles in adaptogen immune enhancement.

The adaptogen NK cells literature is growing and mechanistically coherent. Multiple herbs, including ashwagandha, ginseng, astragalus, and reishi, have shown NK cell-activating or preserving effects. Whether these translate to clinically meaningful infection resistance benefits in healthy, non-immunosuppressed adults remains to be definitively demonstrated.

2024 research deepens our understanding of the molecular mechanisms. The anti-neuroinflammatory findings, including leukotriene synthesis inhibition from eleuthero, ashwagandha, and rhodiola, and NF-κB and MAPK inhibition by gomisin A from schisandra, provide increasingly detailed mechanistic scaffolding for the anti-inflammatory arm of adaptogens immune modulation.

The Long COVID pilot trial result, while limited, keeps the door open. The adaptogen blend's effect on interleukin-6 and other specific endpoints in a difficult-to-treat population is worth following in adequately powered future trials.

Context matters enormously. Adaptogens appear most clinically relevant for immune support in people who are immunologically challenged: the chronically stressed, the elderly, the extreme athlete, the institutionalized. Evidence in young healthy adults with normal cortisol and robust immune function is less compelling, which is also scientifically logical.

Honest expectations are the foundation of good supplementation practice. Adaptogens used appropriately, at evidence-supported doses, from quality manufacturers, and alongside fundamental immune health practices (adequate sleep, balanced nutrition, moderate exercise, social connection, stress management), can be a reasonable adjunctive tool for immune resilience. They are not magic bullets, not replacements for vaccination or medical care, and not uniformly safe for all populations.

The field is evolving. Larger, better-designed randomized controlled trials measuring actual infection incidence as primary endpoints, ideally in diverse populations, are needed to move the strongest hypotheses from "promising" to "established." Readers interested in this space would benefit from following PubMed for new primary research rather than relying solely on supplement industry summaries.

In the meantime, the evidence that does exist supports a measured, informed approach: some adaptogens have real immune-relevant biological activity, some of that activity has been demonstrated in meaningful clinical contexts, and the best current guidance is to use them thoughtfully as part of a comprehensive approach to immune health, with appropriate medical consultation and realistic expectations.

This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement, particularly if you have existing health conditions, take prescription medications, or are pregnant or breastfeeding.

References and Source Notes

• VA Whole Health Library: Adaptogens. [va.gov/WHOLEHEALTHLIBRARY]
• SupplySide Supplement Journal: "4 Adaptogens Emerge for Immunity." [supplysidecj.com]
• UCLA Health: "What Are Adaptogens and Should You Be Taking Them?" [uclahealth.org]
• PMC 2024 Mini-Review: Anti-neuroinflammatory effects of adaptogens
• McGill University: Long COVID adaptogen pilot trial reporting